UdeM’s Biopharmaceutical Unit: playing a key role in drug development
While the COVID-19 pandemic caused slowdowns in many fields, it underscored the importance of UdeM’s drug discovery units.
Médicament Québec is a coordinated initiative to support the development of innovative units dedicated to drug discovery, supply and production in Quebec and to revitalize the province’s pharmaceutical industry. Initially spurred by the need to strengthen the local supply chain, Médicament Québec brings together leading thinkers and infrastructure from universities, colleges and generic and innovative drug companies.
While the COVID-19 pandemic caused slowdowns in many fields, it underscored the importance of UdeM’s drug discovery units.
At the second edition of the IRIC’s Rendez-vous Audace conference, Yoshua Bengio and Sébastien Lemieux explain how artificial intelligence is being used to advance cancer research.
The head of UdeM’s chemistry department thinks this nation can produce enough of its own prescription medications and not have to rely on imports in the fight against COVID-19.